Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly
Žena od 28 godina, s kliničkim obilježjima akromegalije i šećerne bolesti primljena je u naš Refrencijalni centar za kliničku neuroendokrinologiju i bolesti hipofize, Bolnice Sestara Milosrdnica, Zagreb, Hrvatska. Pregled magnetskom rezonancijom pokazao je da bolesnica ima makroadenom hipofize. Nako...
| Permalink: | http://skupni.nsk.hr/Record/nsk.NSK01000703090/Similar |
|---|---|
| Matična publikacija: |
Croatian medical journal 48 (2007), 1 ; str. 87-91 |
| Glavni autor: | Gradišer, Marina (-) |
| Ostali autori: | Matovinović, Martina (-), Vrkljan, Milan |
| Vrsta građe: | Članak |
| Jezik: | eng |
| Predmet: | |
| Online pristup: |
Croatian Medical Journal |
APA stil citiranja
Gradišer, M., Matovinović, M., & Vrkljan, M. (2007). Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly: Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly. Croatian medical journal, p. 8.
Chicago stil citiranjaGradišer, Marina, Martina Matovinović, and Milan Vrkljan. "Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly: Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly." 2007: 8.
MLA stil citiranjaGradišer, Marina, Martina Matovinović, and Milan Vrkljan. "Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly: Decrease in growth hormone and insulin-like growth factor (IGF) - 1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus in a patient with acromegaly." 2007: 8.